ResearcherUniversity Hospital HeidelbergActive in the last 2 years
Ulrich Ronellenfitsch
Matched on ORCID iD 0000-0003-1107-813X; OpenAlex author ID A5020292124. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2019: 1 paper · 2020: none · 2021: 3 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 3 papers
Papers 8
- International survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot. Co-author DOI 10.1016/j.suronc.2026.102580↗
- Hybrid hepatic artery debranching for pancreatic cancer with celiac axis occlusion. Co-author DOI 10.21037/hbsn-2025-714↗
- Surgery in Oligometastatic Pancreatic Cancer: Narrative Systematic Review. Co-author DOI 10.3390/cancers18111699↗
- Future of Pancreatic Cancer Therapy: Getting Better, But not Good Enough Ye. Co-author DOI 10.1016/j.arcmed.2025.103336↗
- Management problems in patients with pancreatic cancer from a surgeon's perspective. First author DOI 10.1053/j.seminoncol.2021.02.008↗
- Do arterial resections improve survival in pancreatic cancer?-a narrative review. First author DOI 10.21037/cco-21-39↗
- Pre-operative/Neoadjuvant Therapy and Vascular Debranching Followed by Resection for Locally Advanced Pancreatic Cancer (PREVADER): Clinical Feasibility Trial. Co-author DOI 10.3389/fmed.2021.588375↗
- Do we need sequential local therapy following neoadjuvant chemotherapy for locally advanced pancreatic cancer? First author DOI 10.1016/j.eclinm.2019.11.015↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jorg H. Kleeff · 7 shared papers, 2019–2026 · strength 1.76
- Paper Surgery in Oligometastatic Pancreatic Cancer: Narrative Systematic Review. DOI 10.3390/cancers18111699↗
- Paper Hybrid hepatic artery debranching for pancreatic cancer with celiac axis occlusion. DOI 10.21037/hbsn-2025-714↗
- Paper Future of Pancreatic Cancer Therapy: Getting Better, But not Good Enough Ye. DOI 10.1016/j.arcmed.2025.103336↗
- Artur Rebelo · 4 shared papers, 2021–2026 · strength 1.22
- Paper Surgery in Oligometastatic Pancreatic Cancer: Narrative Systematic Review. DOI 10.3390/cancers18111699↗
- Paper Hybrid hepatic artery debranching for pancreatic cancer with celiac axis occlusion. DOI 10.21037/hbsn-2025-714↗
- Paper Future of Pancreatic Cancer Therapy: Getting Better, But not Good Enough Ye. DOI 10.1016/j.arcmed.2025.103336↗
- Johannes Klose · 3 shared papers, 2021–2026 · strength 0.88
- Paper Hybrid hepatic artery debranching for pancreatic cancer with celiac axis occlusion. DOI 10.21037/hbsn-2025-714↗
- Paper Future of Pancreatic Cancer Therapy: Getting Better, But not Good Enough Ye. DOI 10.1016/j.arcmed.2025.103336↗
- Paper Management problems in patients with pancreatic cancer from a surgeon's perspective. DOI 10.1053/j.seminoncol.2021.02.008↗
- Jessica Döbereiner · 2 shared papers, 2021–2025 · strength 0.47
- Christoph Michalski · 1 shared paper, 2026 · strength 0.39
- Rosa Klotz · 1 shared paper, 2026 · strength 0.39
- Christoph W. Michalski · 2 shared papers, 2019–2021 · strength 0.32
- Paper Do we need sequential local therapy following neoadjuvant chemotherapy for locally advanced pancreatic cancer? DOI 10.1016/j.eclinm.2019.11.015↗
- Paper Pre-operative/Neoadjuvant Therapy and Vascular Debranching Followed by Resection for Locally Advanced Pancreatic Cancer… DOI 10.3389/fmed.2021.588375↗
- Yoshiaki Sunami · 1 shared paper, 2025 · strength 0.30
- Sebastian Krug · 1 shared paper, 2021 · strength 0.16
- Patrick Michl · 1 shared paper, 2021 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.